Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14065638 | 1.00 | TSHR (0.61) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL12934641 | 0.97 | TSHR (0.61) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL13483552 | 0.97 | TSHR (0.61) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL13023957 | 0.94 | TSHR (0.61) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL4264199 | 0.94 | TSHR (0.69) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL12090657 | 0.94 | TSHR (0.69) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL23787581 | 0.93 | TSHR (0.67) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL12840596 | 0.90 | TSHR (0.63) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL12299088 | 0.90 | TSHR (0.63) | TSHRFAAHHPGDMEN1KMT2A | |
| SCHEMBL16728765 | 0.89 | TSHR (0.61) | TSHRFAAHHPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110220140-A1 | PROCESS FOR THE PERMANENT SHAPING OF HUMAN HAIR | KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) | 2011-09-15 | — | — | US | disclosed |
| US-7862806-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2011-01-04 | — | — | US | disclosed |
| US-7862806-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2011-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110220140-A1 | PROCESS FOR THE PERMANENT SHAPING OF HUMAN HAIR | USP20, USP16, USP21 | TSHR 3926/4885FAAH 3575/4885HPGD 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.